FibroBiologics Inc’s recently made public that its Chief Scientific Officer Khoja Hamid acquired Company’s shares for reported $16800.0 on May 27 ’25. In the deal valued at $0.84 per share,20,000 shares were bought. As a result of this transaction, Khoja Hamid now holds 31,250 shares worth roughly $16562.5.
Rodman & Renshaw initiated its FibroBiologics Inc [FBLG] rating to a Buy in a research note published on December 12, 2024; the price target was $12. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Maxim Group began covering FBLG with “Buy” recommendation on September 24, 2024.
Price Performance Review of FBLG
On Tuesday, FibroBiologics Inc [NASDAQ:FBLG] saw its stock fall -0.45% to $0.53. Over the last five days, the stock has lost -0.68%. FibroBiologics Inc shares have fallen nearly -83.36% since the year began. Nevertheless, the stocks have fallen -73.70% over the past one year. While a 52-week high of $3.89 was reached on 01/07/25, a 52-week low of $0.52 was recorded on 09/23/25.
Levels Of Support And Resistance For FBLG Stock
The 24-hour chart illustrates a support level at 0.5107, which if violated will result in even more drops to 0.4954. On the upside, there is a resistance level at 0.5405. A further resistance level may holdings at 0.5550.
How much short interest is there in FibroBiologics Inc?
A steep rise in short interest was recorded in FibroBiologics Inc stocks on 2025-08-29, dropping by -0.12 million shares to a total of 0.92 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 1.04 million shares. There was a decline of -13.26%, which implies that there is a negative sentiment for the stock.
